vs
Side-by-side financial comparison of El Pollo Loco Holdings, Inc. (LOCO) and SOLENO THERAPEUTICS INC (SLNO). Click either name above to swap in a different company.
El Pollo Loco Holdings, Inc. is the larger business by last-quarter revenue ($126.2M vs $66.0M, roughly 1.9× SOLENO THERAPEUTICS INC). SOLENO THERAPEUTICS INC runs the higher net margin — 39.4% vs 6.5%, a 32.9% gap on every dollar of revenue.
El Pollo Loco, Inc., is a restaurant chain based in the United States, specializing in Mexican-style grilled chicken. Restaurant service consists of dine-in and take-out, with some locations offering drive-through options. The company is headquartered in Costa Mesa, California, and operates about 500 company-owned and franchised restaurants in the Southwestern United States.
SOLENO THERAPEUTICS INC is a clinical-stage biopharmaceutical company specializing in developing novel therapies for rare endocrine, metabolic, and neurodevelopmental disorders. Its lead product candidate targets Prader-Willi syndrome, a rare genetic condition, with key patient markets across North America and the European Union.
LOCO vs SLNO — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $126.2M | $66.0M |
| Net Profit | $8.2M | $26.0M |
| Gross Margin | — | 98.3% |
| Operating Margin | 9.7% | 33.5% |
| Net Margin | 6.5% | 39.4% |
| Revenue YoY | 5.9% | — |
| Net Profit YoY | 48.8% | 134.0% |
| EPS (diluted) | $0.27 | $0.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $126.2M | — | ||
| Q4 25 | $123.5M | — | ||
| Q3 25 | $121.5M | $66.0M | ||
| Q2 25 | $125.8M | $32.7M | ||
| Q1 25 | $119.2M | — | ||
| Q4 24 | $114.3M | — | ||
| Q3 24 | $120.4M | — | ||
| Q2 24 | $122.2M | — |
| Q1 26 | $8.2M | — | ||
| Q4 25 | $6.5M | — | ||
| Q3 25 | $7.4M | $26.0M | ||
| Q2 25 | $7.1M | $-4.7M | ||
| Q1 25 | $5.5M | — | ||
| Q4 24 | $6.0M | — | ||
| Q3 24 | $6.2M | — | ||
| Q2 24 | $7.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 98.3% | ||
| Q2 25 | — | 97.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 8.3% | — | ||
| Q3 25 | 9.4% | 33.5% | ||
| Q2 25 | 9.0% | -20.0% | ||
| Q1 25 | 7.5% | — | ||
| Q4 24 | 7.9% | — | ||
| Q3 24 | 8.4% | — | ||
| Q2 24 | 10.1% | — |
| Q1 26 | 6.5% | — | ||
| Q4 25 | 5.3% | — | ||
| Q3 25 | 6.1% | 39.4% | ||
| Q2 25 | 5.6% | -14.4% | ||
| Q1 25 | 4.6% | — | ||
| Q4 24 | 5.2% | — | ||
| Q3 24 | 5.1% | — | ||
| Q2 24 | 6.2% | — |
| Q1 26 | $0.27 | — | ||
| Q4 25 | $0.22 | — | ||
| Q3 25 | $0.25 | $0.47 | ||
| Q2 25 | $0.24 | $-0.09 | ||
| Q1 25 | $0.19 | — | ||
| Q4 24 | $0.21 | — | ||
| Q3 24 | $0.21 | — | ||
| Q2 24 | $0.25 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.9M | $498.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $302.5M | $494.8M |
| Total Assets | $609.1M | $599.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $3.9M | — | ||
| Q4 25 | $6.2M | — | ||
| Q3 25 | $10.9M | $498.9M | ||
| Q2 25 | $9.0M | $286.8M | ||
| Q1 25 | $4.3M | — | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | $7.9M | — | ||
| Q2 24 | $10.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | $51.0M | — | ||
| Q3 25 | $61.0M | — | ||
| Q2 25 | $69.0M | — | ||
| Q1 25 | $73.0M | — | ||
| Q4 24 | $71.0M | — | ||
| Q3 24 | $76.0M | — | ||
| Q2 24 | $87.0M | — |
| Q1 26 | $302.5M | — | ||
| Q4 25 | $291.1M | — | ||
| Q3 25 | $282.9M | $494.8M | ||
| Q2 25 | $274.2M | $240.1M | ||
| Q1 25 | $265.7M | — | ||
| Q4 24 | $260.7M | — | ||
| Q3 24 | $255.2M | — | ||
| Q2 24 | $248.6M | — |
| Q1 26 | $609.1M | — | ||
| Q4 25 | $606.6M | — | ||
| Q3 25 | $602.7M | $599.9M | ||
| Q2 25 | $596.8M | $332.3M | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $592.0M | — | ||
| Q3 24 | $590.0M | — | ||
| Q2 24 | $593.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.18× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.25× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | 0.27× | — | ||
| Q3 24 | 0.30× | — | ||
| Q2 24 | 0.35× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $43.5M |
| Free Cash FlowOCF − Capex | — | $43.5M |
| FCF MarginFCF / Revenue | — | 65.8% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.67× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $13.9M | — | ||
| Q3 25 | $15.3M | $43.5M | ||
| Q2 25 | $14.1M | $-12.6M | ||
| Q1 25 | $4.7M | — | ||
| Q4 24 | $5.6M | — | ||
| Q3 24 | $13.0M | — | ||
| Q2 24 | $17.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | $5.1M | — | ||
| Q3 25 | $9.9M | $43.5M | ||
| Q2 25 | $9.1M | $-12.6M | ||
| Q1 25 | $1.3M | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $9.1M | — | ||
| Q2 24 | $10.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | 4.1% | — | ||
| Q3 25 | 8.2% | 65.8% | ||
| Q2 25 | 7.2% | -38.6% | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 7.6% | — | ||
| Q2 24 | 8.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 7.1% | — | ||
| Q3 25 | 4.4% | 0.0% | ||
| Q2 25 | 4.0% | 0.0% | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 3.9% | — | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | 5.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.13× | — | ||
| Q3 25 | 2.08× | 1.67× | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 0.95× | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 2.22× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
